Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MaxCyte ( (MXCT) ) just unveiled an update.
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings, with BlackRock, Inc. crossing a significant threshold in voting rights. The notification indicates that BlackRock now holds 7.76% of the voting rights in MaxCyte, reflecting a slight decrease from the previous 7.87%. This adjustment in holdings could have implications for MaxCyte’s governance and influence within the company, as BlackRock is a major player in the financial industry.
More about MaxCyte
YTD Price Performance: -41.51%
Average Trading Volume: 36,307
Technical Sentiment Signal: Strong Buy
Current Market Cap: £203.3M
For an in-depth examination of MXCT stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue